11g, a Potent Antifungal Candidate, Enhances Candida albicans Immunogenicity by Unmasking β-Glucan in Fungal Cell Wall

Frontiers in Microbiology
Xin HuangYuanying Jiang

Abstract

In the course of optimizing GPI biosynthesis inhibitors, we designed and synthetized a 2-aminonicotinamide derivative named 11g. After evaluating the antifungal activity of compound 11g in vitro, we investigated the influences of 11g on fungi immunogenicity. In addition, we also took advantage of murine systemic candidiasis model to investigate the protective effects of 11g in vivo. Results show that 11g exhibited potent antifungal activity both in vitro and in vivo. Further study shows that 11g caused the unmasking of fungi β-glucan layer, leading to stronger immune responses in macrophages through Dectin-1. These results suggest that 11g is a very promising antifungal candidate, which assists in eliciting stronger immune responses to help host immune system disposing pathogens. The discovery of 11g might expand the toolbox of fungal infection treatment.

References

Jul 27, 2002·Annual Review of Microbiology·Leah E CowenLinda M Kohn
Aug 7, 2002·The Journal of Experimental Medicine·Gordon D BrownSiamon Gordon
Nov 6, 2002·The Journal of Biological Chemistry·Sudeepta AggarwalAustin L Gurney
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Apr 30, 2003·The Journal of Experimental Medicine·Gordon D BrownSiamon Gordon
Apr 30, 2003·The Journal of Experimental Medicine·Benjamin N GantnerDavid M Underhill
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olafur GudlaugssonDaniel Diekema
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mihai G NeteaBart Jan Kullberg
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Sep 11, 2004·Current Opinion in Microbiology·Daniel Poulain, Thierry Jouault
Feb 25, 2005·The EMBO Journal·Benjamin N GantnerDavid M Underhill
Apr 27, 2005·Annals of Clinical Microbiology and Antimicrobials·Chandrasekhar KesavanNatarajan Ganesan
May 5, 2005·Microbiology·Bruce L GrangerJim E Cutler
Oct 7, 2005·Cellular Microbiology·Carol A Kumamoto, Marcelo D Vinces
Jan 21, 2006·The Journal of Clinical Investigation·Roger P M SutmullerGosse J Adema
May 3, 2006·PLoS Pathogens·Robert T Wheeler, Gerald R Fink
Dec 26, 2006·Eukaryotic Cell·Mathias L Richard, Armêl Plaine
Dec 15, 2007·Nature Reviews. Microbiology·Mihai G NeteaNeil A R Gow
Sep 6, 2008·Microbiology and Molecular Biology Reviews : MMBR·W LaJean Chaffin
Mar 9, 2010·Trends in Microbiology·David W Denning, William W Hope
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P KontoyiannisPeter G Pappas
May 11, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John W BaddleyPeter G Pappas
Jun 25, 2010·Bioorganic & Medicinal Chemistry Letters·Kazutaka NakamotoKatsura Hata
Jun 26, 2010·Microbiology·Guiliana Soraya VictoriaSneha Sudha Komath
Aug 10, 2011·Antimicrobial Agents and Chemotherapy·Mamiko MiyazakiMakoto Asada
Dec 14, 2011·Nature Reviews. Microbiology·Neil A R GowMihai G Netea
Jan 21, 2012·Methods in Molecular Biology·André Moraes Nicola, Arturo Casadevall
May 23, 2012·Current Opinion in Immunology·Salomé LeibundGut-LandmannTobias M Hohl
Jun 26, 2012·ACS Chemical Biology·Catherine A McLellanSusan Lindquist
Nov 16, 2013·Nature Reviews. Microbiology·Antonio Cassone
Oct 2, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chaoyu MaGuili Xu

❮ Previous
Next ❯

Citations

Dec 16, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Xin HuangBingdi Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
transmission electron microscopy
nuclear translocation

Software Mentioned

Image J
Prism
GraphPad

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.